NextGen Patient Voice

NextGen Patient Voice explores how research, AI, and public policy are transforming patient advocacy. Each episode breaks down the ideas, tools, and decisions shaping the future of healthcare, with a focus on what they mean for patients, caregivers, and advocates. Clear, practical, and forward-looking, this podcast connects innovation to real-world patient impact.

NextGen Patient Voice is a science podcast hosted by Peter Loupos, with 9 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Peter Loupos hosts NextGen Patient Voice, a science show with 9 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  NextGen Patient Voice

  AI in Health, Medicare Bundles, Baptist Health Expands, Device Recalls, and CAR T-Cell Innovations

  Apr 18, 20265 minS0

  <p>In this episode, we explore key developments in the healthcare sector. Five leaders in health technology prioritize advancements in AI, while Medicare expands its Comprehensive Care for Joint Replacement Model, marking a significant shift in payment structures. Baptist Health plans to acquire two community hospitals in Arkansas, and a lawsuit involving Aetna and Radiology Partners under the No Surprises Act has been dismissed. A growing dispute over the Medicare wage index presents challenges for hospitals.</p> <p>A surge in recalls of diabetes devices in 2025 raises patient safety concerns, with Class I recalls involving Abbott, Tandem Diabetes Care, and...

  ListenShow Notes
• 

  NextGen Patient Voice

  CMS Proposes FY 2027 Medicare Updates; AMGA & Talkiatry Partner for Mental Health Access

  Apr 16, 20269 minS0

  <p>In this episode, we explore the latest updates in healthcare and medical research. The CMS has proposed Medicare payment increases for skilled nursing facilities, hospices, inpatient rehabilitation, and psychiatric facilities for FY 2027, with a focus on enhancing quality reporting and oversight. The May 28, 2024 issue of JAMA highlights advancements in cardiovascular health, telemedicine, and mental health interventions. The AMGA partners with Talkiatry to improve psychiatric care access, while CMS announces participants in Medicare’s ACCESS Model. The New England Journal of Medicine reports on the use of CD19 CAR T-cell therapy for autoimmune hemolytic anemia, showing promise for broader autoimmune ap...

  ListenShow Notes
• 

  NextGen Patient Voice

  Unlocking Asthma Relief: The AIRLYMPUS Study's Quest for Better Breathing Solutions

  Mar 31, 20266 minS0

  <p>The AIRLYMPUS Study is investigating a new drug for adults with asthma to see if it can improve breathing, alleviate symptoms, and reduce future attacks when added to standard therapy. Eligible participants are aged 18-80, have had asthma for at least a year, and are on daily treatment.</p> <p>The BLU-808-1201 study is seeking participants with chronic spontaneous urticaria who still experience symptoms despite antihistamine use. This study involves an oral tablet, lab tests, and monitoring, with reimbursement for expenses.</p> <p>A Phase 2b trial for EVO756, an investigational therapy for atopic dermatitis, is enrolling adults...

  ListenShow Notes
• 

  NextGen Patient Voice

  "Rare Disease Advocacy, AI in Healthcare, and Novo Nordisk's 340B Oversight: Key Updates"

  Mar 5, 20269 minS0

  <p>During Rare Disease Week, families across the nation are advocating for better access to treatments and clinical trials. A Colorado family highlights the challenges faced by rare disease patients after a crucial clinical trial for their son was abruptly terminated, underscoring the need for legislative and policy changes.</p> <p>NEJM AI emphasizes the importance of rigorous randomized control trials in the development of AI in healthcare, focusing on ensuring reliability and effectiveness while balancing technological advancement with ethical considerations.</p> <p>The JAMA Network offers a comprehensive collection of research on psychiatry and behavioral health, providing valuable insights...

  ListenShow Notes
• 

  NextGen Patient Voice

  Gene Therapy Partnership, CVS GLP-1 Strategy, Moderna's mRNA Settlement, and Health Tech Shifts

  Mar 4, 20265 minS0

  <p>In this episode, we explore several key developments in the healthcare and biotech sectors. Cure Rare Disease and the LGMD2L Foundation have partnered to develop a gene therapy for Anoctamin 5-related disease, backed by $7.65 million. This collaboration aims to move a treatment from design to clinical trials, highlighting the role of patient-led organizations in rare disease research.</p> <p>A new clinical trial led by the University of Manchester is examining cognitive analytic therapy for young people who self-harm, aiming to assess its effectiveness in addressing this growing issue among UK youths.</p> <p>CVS Caremark's strategic plan...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.